Skip to main content
Retour
GHRS logo

GH Research PLC

Qualité des données : 100%
GHRS
NASDAQ Healthcare Biotechnology
13,21 €
▼ 0,76 € (-5,44%)
Cap. Boursière : 819,41M
Fourchette du Jour
13,12 € 14,19 €
Fourchette 52 Semaines
7,98 € 19,51 €
Volume
291 900
Moyenne 50J / 200J
15,62 € / 14,17 €
Clôture Précédente
13,97 €

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Healthcare (626 pairs)

Métrique Action Médiane du Secteur
P/E -17,0 0,4
P/B 2,9 2,9
ROE % -21,0 3,7
Net Margin % 3,8
Rev Growth 5Y % 10,0
D/E 0,0 0,2

Points Clés

Debt/Equity of 0,00 — conservative balance sheet
Negative free cash flow of -43,67M

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
-21,04%
ROIC-16,24%
Net MarginN/A
Op. MarginN/A

Sécurité

Debt / Equity
0,00
Current Ratio34,13
Interest Coverage-131,05

Valorisation

P/E Ratio
-16,98
P/B Ratio2,93
EV/EBITDAN/A
Dividend Yield0,00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 0,0 Net Income (TTM) -48,26M
ROE -21,04% ROA -16,74%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -43,67M
ROIC -16,24% FCF Growth (3Y) N/A
Safety
Debt / Equity 0,00 Current Ratio 34,13
Interest Coverage -131,05 Dividend Yield 0,00%
Valuation
P/E Ratio -16,98 P/B Ratio 2,93
P/S Ratio N/A PEG Ratio -3,01
EV/EBITDA N/A Dividend Yield 0,00%
Market Cap 819,41M Enterprise Value 573,67M

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 0,0 0,0 0,0 0,0 0,0
Net Income -48,26M -38,96M -35,59M -22,46M -9,20M
EPS (Diluted) -0,79 -0,75 -0,68 -0,14 -0,18
Gross Profit -335 000,0 0,0 0,0 0,0 0,0
Operating Income -60,68M -50,31M -41,22M -30,55M -15,10M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 288,23M 188,27M 226,30M 254,36M 279,92M
Total Liabilities 8,53M 9,32M 7,33M 4,55M 2,75M
Shareholders' Equity 279,70M 178,95M 218,97M 249,82M 277,18M
Total Debt 512 000,0 624 000,0 974 000,0 0,0 0,0
Cash & Equivalents 246,25M 100,79M 78,42M 165,96M 276,78M
Current Assets 285,98M 154,23M 164,09M 168,54M 279,84M
Current Liabilities 8,38M 8,95M 6,70M 4,55M 2,75M